JENNALYN MAYEUX: Open Payments
NPI 1447514120 · SALT LAKE CITY, UT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$43,028 in 113 payments from 6 companies in 2025. Trend: 2023 $34,486 · 2024 $35,030 · 2025 $43,028
Speaker / faculty: $22,304Consulting: $9,555Travel & lodging: $8,737Food & beverage: $2,174Education: $258
| Company | Payments | Amount |
|---|---|---|
| Actelion Pharmaceuticals US, Inc. | 70 | $25,212 |
| Merck Sharp & Dohme LLC | 23 | $11,717 |
| Johnson & Johnson Health Care Systems Inc. | 10 | $5,809 |
| United Therapeutics Corporation | 5 | $162 |
| Insmed, Inc. | 4 | $112 |
| Sandoz Inc. | 1 | $16 |
Products named: UPTRAVI, WINREVAIR, OPSUMIT, Arikayce, Tyvaso, TREPROSTINIL, OPSYNVI.
Industry payments across UT — which companies pay providers there.
